Sharechat Logo

Genesis follows market in downward spiral

By Phil Boeyen, ShareChat Business News Editor

Friday 22nd September 2000

Text too small?
Newly listed bio-tech stock Genesis hit the ground running but like most of the market fell back strongly during the day to close at $6.49 compared with its listing price of $6.00. The stock opened its market debut at $8.48.

The other new listing this week, telco software group CommSoft, was also sold down, losing 18 cents to close at $1.42.

CommSoft's fall mirrored many others in the tech sector including E-cademy, Spectrum, Advantage, Savoy, Strathmore and E-Phone.

Market bellwether Telecom fell 15 cents to finish at yet another recent low of $5.85.

The extent of the tech slide is notable in Iguana Services' 4i index, which follows IT and Internet companies. The 4i index started at a base of 1000 on January 1 this year and is currently sitting below 800.

Among Friday's stock improvements were investment company Utilico, which added 4 cents to 36 after announcing a plan to give $20 million in cash back to shareholders. Natural Gas rose 6 cents to $1.43 after the Hutt Mana Energy Trust agreed to accept its offer to buy the Trust's stake in energy company Trans Alta.

The NZSE 40 closed Friday at 1974, falling 37 points for the day and 80 points for the week.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Genesis Research directors quit due to lack of funds & communication
Genesis Research has ‘lack of funds’, seeks legal advice on future
Genesis Research halted from trading pending statement
Genesis Research calls off proposed merger with Mariposa Health
Kupe earnings bolster Genesis 1H profit by 125%
Genesis Research plans "reverse takeover"
Genesis Research director Graham Chin resigns in wake of rift with UBNZ
Tekapo purchase knocks $73m off Genesis bottom line
UBNZ gets in deeper with Genesis Research
Genesis Energy beats forecast